Metallopharmaceutical

Carboplatin

2D skeletal structure of Carboplatin

Carboplatin is a chemotherapy medication used to treat various types of cancer, including ovarian cancer, lung cancer, and testicular cancer. It is a platinum-based antineoplastic agent, which means it contains the metal platinum and is used to inhibit the growth of cancer cells.

Mechanism of Action

Carboplatin works by interfering with the DNA of cancer cells. It forms cross-links between DNA strands, which prevents the cells from dividing and growing. This ultimately leads to apoptosis, or programmed cell death, of the cancer cells. The drug is less reactive than its predecessor, cisplatin, which results in fewer side effects.

Administration

Carboplatin is typically administered via intravenous infusion. The dosage and schedule depend on the type of cancer being treated, the patient's overall health, and other factors. It is often used in combination with other chemotherapy drugs to enhance its effectiveness.

Side Effects

Common side effects of carboplatin include nausea, vomiting, fatigue, and myelosuppression, which is a decrease in the production of blood cells. This can lead to anemia, increased risk of infection, and bleeding. Less common side effects include allergic reactions, hearing loss, and kidney damage.

Comparison with Cisplatin

Carboplatin is often compared to cisplatin, another platinum-based chemotherapy drug. While both drugs have similar mechanisms of action, carboplatin is generally associated with fewer side effects, particularly nephrotoxicity and ototoxicity. However, it may be less effective in certain types of cancer.

Related Pages

• Cisplatin
• Chemotherapy
• Ovarian cancer
• Lung cancer
• Testicular cancer